C2 C Wealth Management, LLC Bio Rad Laboratories, Inc. Transaction History
C2 C Wealth Management, LLC
- $106 Million
- Q1 2025
A detailed history of C2 C Wealth Management, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, C2 C Wealth Management, LLC holds 1,715 shares of BIO stock, worth $423,707. This represents 0.39% of its overall portfolio holdings.
Number of Shares
1,715
Previous 1,715
-0.0%
Holding current value
$423,707
Previous $563,000
25.93%
% of portfolio
0.39%
Previous 0.52%
Shares
2 transactions
Others Institutions Holding BIO
# of Institutions
460Shares Held
18.9MCall Options Held
12.7KPut Options Held
14.4K-
Vanguard Group Inc Valley Forge, PA1.91MShares$472 Million0.01% of portfolio
-
First Eagle Investment Management, LLC1.57MShares$387 Million0.8% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$383 Million0.01% of portfolio
-
Veritas Asset Management LLP913KShares$226 Million2.52% of portfolio
-
Dimensional Fund Advisors LP Austin, TX877KShares$217 Million0.05% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.09B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...